Skip to main content
Top
Published in: General Thoracic and Cardiovascular Surgery 1/2019

01-01-2019 | SPECIAL EDITION

How to treat aortic graft infection? With a special emphasis on xeno-pericardial aortic tube grafts

Authors: Thierry Carrel, Lars Englberger, Jürg Schmidli

Published in: General Thoracic and Cardiovascular Surgery | Issue 1/2019

Login to get access

Abstract

Infection of a vascular prosthesis or endovascular stent-graft is probably the most serious complication that may occur after implantation and dramatically affects the patient’s outcome. The most common etiology of graft and/or prosthetic valve infection is usually wound-related infection, followed by seeding from distant infection sites (lung, urinary tract). Surgical treatment is almost always required but even after surgery, morbidity can be significant. Operative procedure must be tailored according to the individual patient and to the experience of the surgical team. Complete resection of the infected foreign material with débridement of the surrounding tissue gives most probably the best results. Orthotopic reconstruction is the best option for all thoracic and thoraco-abdominal pathologies and the use of coated prostheses, industrially fabricated bio-conduits, homografts or self-made vascular tubes from xenopericardial tissue has to be discussed from case to case. In some exceptional situations, endovascular stent-graft can be performed as bridging to a more complete treatment if general condition of the patient has to be stabilized.
Literature
1.
go back to reference Berger P, Vaartjes I, Moll FL, De Borst GJ, Blankensteijn JD, Bots ML. Cumulative incidence of graft infection after primary prosthetic aortic reconstruction in the endovascular era. Eur J Vasc Endovasc Surg. 2015;49:581–5.CrossRefPubMed Berger P, Vaartjes I, Moll FL, De Borst GJ, Blankensteijn JD, Bots ML. Cumulative incidence of graft infection after primary prosthetic aortic reconstruction in the endovascular era. Eur J Vasc Endovasc Surg. 2015;49:581–5.CrossRefPubMed
2.
go back to reference Vogel TR, Symons R, Flum DR. The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg. 2008;47:264–9.CrossRefPubMed Vogel TR, Symons R, Flum DR. The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg. 2008;47:264–9.CrossRefPubMed
3.
go back to reference O’Connor S, Andrew P, Batt M, Becquemin JP. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg. 2006;44(1):38–45.CrossRefPubMed O’Connor S, Andrew P, Batt M, Becquemin JP. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg. 2006;44(1):38–45.CrossRefPubMed
4.
go back to reference Cernohorsky P, Reijnen MM, Tielliu IF, van Sterkenburg SM, van den Dungen JJ, Zeebregts CJ. The relevance of aortic endograft prosthetic infection. J Vasc Surg. 2011;54(2):327–33.CrossRefPubMed Cernohorsky P, Reijnen MM, Tielliu IF, van Sterkenburg SM, van den Dungen JJ, Zeebregts CJ. The relevance of aortic endograft prosthetic infection. J Vasc Surg. 2011;54(2):327–33.CrossRefPubMed
5.
go back to reference Lyons OT, Patel AS, Saha P, Clough RE, Price N, Taylor PR. A 14-year experience with aortic endograft infection: management and results. Eur J Vasc Endovasc Surg. 2013;46(3):306–13.CrossRefPubMed Lyons OT, Patel AS, Saha P, Clough RE, Price N, Taylor PR. A 14-year experience with aortic endograft infection: management and results. Eur J Vasc Endovasc Surg. 2013;46(3):306–13.CrossRefPubMed
6.
go back to reference Greaves NS, Katsogridakis E, Faris B, Murray D. Prophylactic antibiotics for percutaneous endovascular procedures. Eur J Clin Microbiol Infect Dis. 2017;36:597–601.CrossRefPubMed Greaves NS, Katsogridakis E, Faris B, Murray D. Prophylactic antibiotics for percutaneous endovascular procedures. Eur J Clin Microbiol Infect Dis. 2017;36:597–601.CrossRefPubMed
8.
go back to reference Lyons OT, Baguneid M, Barwick TD, Bell RE, Foster N, Homer-Vanniasinkam S, et al. Diagnosis of aortic graft infection: a case definition by the management of aortic graft infection collaboration (MAGIC). Eur J Vasc Endovasc Surg. 2016;52:758–63.CrossRefPubMed Lyons OT, Baguneid M, Barwick TD, Bell RE, Foster N, Homer-Vanniasinkam S, et al. Diagnosis of aortic graft infection: a case definition by the management of aortic graft infection collaboration (MAGIC). Eur J Vasc Endovasc Surg. 2016;52:758–63.CrossRefPubMed
9.
go back to reference Hargrove WC, Edmunds LH. Management of infected thoracic aortic prosthetic grafts. Ann Thorac Surg. 1984;37:72–7.CrossRefPubMed Hargrove WC, Edmunds LH. Management of infected thoracic aortic prosthetic grafts. Ann Thorac Surg. 1984;37:72–7.CrossRefPubMed
10.
go back to reference Coselli JS, Köksoy C, LeMaire SA. Management of thoracic aortic graft infections. Ann Thorac Surg. 1999;67:1990–3.CrossRefPubMed Coselli JS, Köksoy C, LeMaire SA. Management of thoracic aortic graft infections. Ann Thorac Surg. 1999;67:1990–3.CrossRefPubMed
11.
go back to reference Fatima J, Duncan AA, de Grandis E, Oderich GS, Kalra M, Gloviczki P, et al. Treatment strategies and outcomes in patients with infected aortic endografts. J Vasc Surg. 2013;58(2):371–9.CrossRefPubMed Fatima J, Duncan AA, de Grandis E, Oderich GS, Kalra M, Gloviczki P, et al. Treatment strategies and outcomes in patients with infected aortic endografts. J Vasc Surg. 2013;58(2):371–9.CrossRefPubMed
12.
go back to reference LeMaire SA, Coselli JS. Options for managing infected ascending aortic grafts. J Thorac Cardiovasc Surg. 2007;134:839–43.CrossRefPubMed LeMaire SA, Coselli JS. Options for managing infected ascending aortic grafts. J Thorac Cardiovasc Surg. 2007;134:839–43.CrossRefPubMed
13.
go back to reference O’Connor S, Andrew P, Batt M, Becquemin JP. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg. 2006;44:38–45.CrossRefPubMed O’Connor S, Andrew P, Batt M, Becquemin JP. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg. 2006;44:38–45.CrossRefPubMed
14.
go back to reference Nakajima N, Masuda M, Ichinose M, Ando M. A new method for the treatment of graft infection in the thoracic aorta: in situ preservation. Ann Thorac Surg. 1999;67:1994–6.CrossRefPubMed Nakajima N, Masuda M, Ichinose M, Ando M. A new method for the treatment of graft infection in the thoracic aorta: in situ preservation. Ann Thorac Surg. 1999;67:1994–6.CrossRefPubMed
15.
go back to reference Tossios P, Karatzopoulos A, Tsagakis K, Sapalidis K, Grosomanidis V, Kalogera A, Kouskouras K, Foroulis CN, Anastasiadis K. Treatment of infected thoracic aortic prosthetic grafts with the in situ preservation strategy: a review of its history, surgical technique, and results. Heart Lung Circ. 2014;23:24–31.CrossRefPubMed Tossios P, Karatzopoulos A, Tsagakis K, Sapalidis K, Grosomanidis V, Kalogera A, Kouskouras K, Foroulis CN, Anastasiadis K. Treatment of infected thoracic aortic prosthetic grafts with the in situ preservation strategy: a review of its history, surgical technique, and results. Heart Lung Circ. 2014;23:24–31.CrossRefPubMed
16.
go back to reference Umminger J, Krueger H, Beckmann E, Kaufeld T, Fleissner F, Haverich A, Shrestha M, Martens A. Management of early graft infections in the ascending aorta and aortic arch: a comparison between graft replacement and graft preservation techniques. Eur J Cardiothorac Surg. 2016;50:660–7.CrossRefPubMed Umminger J, Krueger H, Beckmann E, Kaufeld T, Fleissner F, Haverich A, Shrestha M, Martens A. Management of early graft infections in the ascending aorta and aortic arch: a comparison between graft replacement and graft preservation techniques. Eur J Cardiothorac Surg. 2016;50:660–7.CrossRefPubMed
17.
go back to reference Chervu A1, Moore WS, Gelabert HA, Colburn MD, Chvapil M. Prevention of graft infection by use of prostheses bonded with a rifampin/collagen release system. J Vasc Surg. 1991;14:521–4 (discussion 524–5).CrossRefPubMed Chervu A1, Moore WS, Gelabert HA, Colburn MD, Chvapil M. Prevention of graft infection by use of prostheses bonded with a rifampin/collagen release system. J Vasc Surg. 1991;14:521–4 (discussion 524–5).CrossRefPubMed
18.
go back to reference Oderich GS, Bower TC, Hofer J, Kalra M, Duncan AA, Wilson JW, et al. In situ rifampin-soaked grafts with omental coverage and antibiotic suppression are durable with low reinfection rates in patients with aortic graft enteric erosion or fistula. J Vasc Surg. 2011;53:99–106, 7e1–7 (discussion 7).CrossRefPubMed Oderich GS, Bower TC, Hofer J, Kalra M, Duncan AA, Wilson JW, et al. In situ rifampin-soaked grafts with omental coverage and antibiotic suppression are durable with low reinfection rates in patients with aortic graft enteric erosion or fistula. J Vasc Surg. 2011;53:99–106, 7e1–7 (discussion 7).CrossRefPubMed
19.
go back to reference Pupka A, Skora J, Janczak D, Plonek T, Marczak J, Szydelko T. In situ revascularisation with silver-coated polyester prostheses and arterial homografts in patients with aortic graft infection—a prospective, comparative, single-centre study. Eur J Vasc Endovasc Surg. 2011;41:61–7.CrossRefPubMed Pupka A, Skora J, Janczak D, Plonek T, Marczak J, Szydelko T. In situ revascularisation with silver-coated polyester prostheses and arterial homografts in patients with aortic graft infection—a prospective, comparative, single-centre study. Eur J Vasc Endovasc Surg. 2011;41:61–7.CrossRefPubMed
20.
go back to reference Goëau-Brissonière O, Leport C, Bacourt F, Lebrault C, Comte R, Pechère JC. Prevention of vascular graft infection by rifampicin bonding to a gelatin-sealed dacron graft. Ann Vasc Surg. 1999;5:408–12.CrossRef Goëau-Brissonière O, Leport C, Bacourt F, Lebrault C, Comte R, Pechère JC. Prevention of vascular graft infection by rifampicin bonding to a gelatin-sealed dacron graft. Ann Vasc Surg. 1999;5:408–12.CrossRef
21.
go back to reference Zegelman M1, Guenther G, Waliszewski M, Pukacki F, Stanisic MG, Piquet P, Passon M, Halloul Z, Tautenhahn J, Claey L, Agostinho C, Simici D, Doebrich D, Mueller C, Balzer K. Results from the International Silver Graft Registry for high-risk patients treated with a metallic-silver impregnated vascular graft. Vascular. 2013;21:137–47.CrossRefPubMed Zegelman M1, Guenther G, Waliszewski M, Pukacki F, Stanisic MG, Piquet P, Passon M, Halloul Z, Tautenhahn J, Claey L, Agostinho C, Simici D, Doebrich D, Mueller C, Balzer K. Results from the International Silver Graft Registry for high-risk patients treated with a metallic-silver impregnated vascular graft. Vascular. 2013;21:137–47.CrossRefPubMed
22.
go back to reference Carrel TP, Berdat P, Englberger L, Eckstein F, Immer F, Seiler C, Kipfer B. Schmidli J. Aortic root replacement with a new stentless aortic valve xenograft conduit: preliminary hemodynamic and clinical results. J Heart Valve Dis. 2003;12:752–7.PubMed Carrel TP, Berdat P, Englberger L, Eckstein F, Immer F, Seiler C, Kipfer B. Schmidli J. Aortic root replacement with a new stentless aortic valve xenograft conduit: preliminary hemodynamic and clinical results. J Heart Valve Dis. 2003;12:752–7.PubMed
23.
go back to reference Siniawski H, Lehmkuhl H, Weng Y, Pasic M, Yankah C, Hoffmann M, Behnke I, Hetzer R. Stentless aortic valves as an alternative to homografts for valve replacement in active infective endocarditis complicated by ring abscess. Ann Thorac Surg. 2003;75:803–8.CrossRefPubMed Siniawski H, Lehmkuhl H, Weng Y, Pasic M, Yankah C, Hoffmann M, Behnke I, Hetzer R. Stentless aortic valves as an alternative to homografts for valve replacement in active infective endocarditis complicated by ring abscess. Ann Thorac Surg. 2003;75:803–8.CrossRefPubMed
24.
go back to reference Carrel TP, Schoenhoff FS, Schmidli J, Stalder M, Eckstein FS, Englberger L. Deleterious outcome of no-react-treated stentless valved conduits after aortic root replacement: why were warnings ignored? J Thorac Cardiovasc Surg. 2008;136:52–7.CrossRefPubMed Carrel TP, Schoenhoff FS, Schmidli J, Stalder M, Eckstein FS, Englberger L. Deleterious outcome of no-react-treated stentless valved conduits after aortic root replacement: why were warnings ignored? J Thorac Cardiovasc Surg. 2008;136:52–7.CrossRefPubMed
25.
go back to reference Reineke DC, Kaya A, Heinisch PP, Oezdemir B, Winkler B, Huber C, Heijmen RH, Morshuis W, Carrel TP, Englberger L. Long-term follow-up after implantation of the Shelhigh® No-React® complete biological aortic valved conduit. Eur J Cardiothorac Surg. 2016;50:98–104.CrossRefPubMed Reineke DC, Kaya A, Heinisch PP, Oezdemir B, Winkler B, Huber C, Heijmen RH, Morshuis W, Carrel TP, Englberger L. Long-term follow-up after implantation of the Shelhigh® No-React® complete biological aortic valved conduit. Eur J Cardiothorac Surg. 2016;50:98–104.CrossRefPubMed
26.
go back to reference Calderon E, Spina A, Camurri N, Bellieni L, Bentini C, Pugliese P. Early failure of Shelhigh bioconduit in aortic position: an underestimated drawback. Berlin: Fifth Biennal Meeting of the Society of Heart Valve Disease; 2009. Calderon E, Spina A, Camurri N, Bellieni L, Bentini C, Pugliese P. Early failure of Shelhigh bioconduit in aortic position: an underestimated drawback. Berlin: Fifth Biennal Meeting of the Society of Heart Valve Disease; 2009.
27.
go back to reference Guenther SP, Reichelt A, Peterss S, Luehr M, Bagaev E, Hagl C, Pichlmaier MA, Khaladj N. Root replacement for graft infection using an all-biologic xenopericardial conduit. J Heart Valve Dis. 2016;25:440–7.PubMed Guenther SP, Reichelt A, Peterss S, Luehr M, Bagaev E, Hagl C, Pichlmaier MA, Khaladj N. Root replacement for graft infection using an all-biologic xenopericardial conduit. J Heart Valve Dis. 2016;25:440–7.PubMed
28.
go back to reference Guihaire J, Kloeckner M, Deleuze P. Exclusion of complex paraannular aortic abscess with the freestyle xenograft. Ann Thorac Surg. 2016;102:e373–5.CrossRef Guihaire J, Kloeckner M, Deleuze P. Exclusion of complex paraannular aortic abscess with the freestyle xenograft. Ann Thorac Surg. 2016;102:e373–5.CrossRef
29.
go back to reference Schneider AW, Hazekamp MG, Versteegh MI, Bruggemans EF, Holman ER, Klautz RJ, Braun J. Stentless bioprostheses: a versatile and durable solution in extensive aortic valve endocarditis. Eur J Cardiothorac Surg. 2016;49:1699–704.CrossRefPubMed Schneider AW, Hazekamp MG, Versteegh MI, Bruggemans EF, Holman ER, Klautz RJ, Braun J. Stentless bioprostheses: a versatile and durable solution in extensive aortic valve endocarditis. Eur J Cardiothorac Surg. 2016;49:1699–704.CrossRefPubMed
30.
go back to reference Bahnini A, Ruotolo C, Koskas F, Kieffer E. In situ fresh allograft replacement of an infected aortic prosthetic graft: eighteen months’ follow-up. J Vasc Surg. 1991;14:98–102.CrossRefPubMed Bahnini A, Ruotolo C, Koskas F, Kieffer E. In situ fresh allograft replacement of an infected aortic prosthetic graft: eighteen months’ follow-up. J Vasc Surg. 1991;14:98–102.CrossRefPubMed
31.
go back to reference Chiesa R, Astore D, Piccolo G, Melissano G, Jannello A, Frigerio D, et al. Fresh and cryopreserved arterial homografts in the treatment of prosthetic graft infections: experience of the Italian Collaborative Vascular Homograft Group. Ann Vasc Surg. 1998;12:457–62.CrossRefPubMed Chiesa R, Astore D, Piccolo G, Melissano G, Jannello A, Frigerio D, et al. Fresh and cryopreserved arterial homografts in the treatment of prosthetic graft infections: experience of the Italian Collaborative Vascular Homograft Group. Ann Vasc Surg. 1998;12:457–62.CrossRefPubMed
32.
go back to reference Zhou W, Lin PH, Bush RL, Terramani TT, Matsuura JH, Cox M, et al. In situ reconstruction with cryopreserved arterial allografts for management of mycotic aneurysms or aortic prosthetic graft infections a multi-institutional experience. Tex Heart Inst J 2006;33:14–8. Zhou W, Lin PH, Bush RL, Terramani TT, Matsuura JH, Cox M, et al. In situ reconstruction with cryopreserved arterial allografts for management of mycotic aneurysms or aortic prosthetic graft infections a multi-institutional experience. Tex Heart Inst J 2006;33:14–8.
33.
go back to reference Vogt PR, Turina MI. Management of infected aortic grafts: development of less invasive surgery using cryopreserved homografts. Ann Thorac Surg. 1999;67:1986–9.CrossRefPubMed Vogt PR, Turina MI. Management of infected aortic grafts: development of less invasive surgery using cryopreserved homografts. Ann Thorac Surg. 1999;67:1986–9.CrossRefPubMed
34.
go back to reference Minga Lowampa E, Holemans C, Stiennon L, Van Damme H, Defraigne JO. Late fate of cryopreserved arterial allografts. Eur J Vasc Endovasc Surg. 2016;52:696–702.CrossRefPubMed Minga Lowampa E, Holemans C, Stiennon L, Van Damme H, Defraigne JO. Late fate of cryopreserved arterial allografts. Eur J Vasc Endovasc Surg. 2016;52:696–702.CrossRefPubMed
35.
go back to reference Czerny M, von Allmen R, Opfermann P, Sodeck G, Dick F, Stellmes A, et al. Self-made pericardial tube graft: a new surgical concept for treatment of graft infections after thoracic and abdominal aortic procedures. Ann Thorac Surg. 2011;92:1657–62.CrossRefPubMed Czerny M, von Allmen R, Opfermann P, Sodeck G, Dick F, Stellmes A, et al. Self-made pericardial tube graft: a new surgical concept for treatment of graft infections after thoracic and abdominal aortic procedures. Ann Thorac Surg. 2011;92:1657–62.CrossRefPubMed
36.
go back to reference Oda T, Minatoya K, Kobayashi J, Okita Y, Akashi H, Tanaka H, Kawaharada N, Saiki Y, Kuniyoshi Y, Nishimura K. Prosthetic vascular graft infection through a median sternotomy: a multicentre review. Interact Cardiovasc Thorac Surg. 2015;20:701–6.CrossRefPubMed Oda T, Minatoya K, Kobayashi J, Okita Y, Akashi H, Tanaka H, Kawaharada N, Saiki Y, Kuniyoshi Y, Nishimura K. Prosthetic vascular graft infection through a median sternotomy: a multicentre review. Interact Cardiovasc Thorac Surg. 2015;20:701–6.CrossRefPubMed
37.
go back to reference Samoukovic G, Bernier PL, Lachapelle K.Successful. Treatment of infected ascending aortic prosthesis by omental wrapping without graft removal. Ann Thorac Surg. 2008;86:287–9.CrossRefPubMed Samoukovic G, Bernier PL, Lachapelle K.Successful. Treatment of infected ascending aortic prosthesis by omental wrapping without graft removal. Ann Thorac Surg. 2008;86:287–9.CrossRefPubMed
38.
go back to reference Krabatsch I, Hetzer R. Infected ascending aortic prosthesis: successful treatment by thoracic transposition of the greater omentum. Eur J Cardio-thorac Surg. 1995;9:223–5.CrossRef Krabatsch I, Hetzer R. Infected ascending aortic prosthesis: successful treatment by thoracic transposition of the greater omentum. Eur J Cardio-thorac Surg. 1995;9:223–5.CrossRef
39.
go back to reference Luciani N, Lapenna E, De Bonis M, Possati GF. Mediastinitis following graft replacement of the ascending aorta: conservative approach by omental transposition. Eur J Cardiothorac Surg. 2001;20:418–20.CrossRefPubMed Luciani N, Lapenna E, De Bonis M, Possati GF. Mediastinitis following graft replacement of the ascending aorta: conservative approach by omental transposition. Eur J Cardiothorac Surg. 2001;20:418–20.CrossRefPubMed
40.
go back to reference Fujii T, Watanabe Y. Multidisciplinary treatment approach for prosthetic vascular graft infection in the thoracic aortic area. Ann Thorac Cardiovasc Surg. 2015;21:418–27.CrossRefPubMedPubMedCentral Fujii T, Watanabe Y. Multidisciplinary treatment approach for prosthetic vascular graft infection in the thoracic aortic area. Ann Thorac Cardiovasc Surg. 2015;21:418–27.CrossRefPubMedPubMedCentral
41.
go back to reference Inoue H, Iguro Y, Yamamoto H, Ueno M, Higashi A, Tao K, et al. Palliative stent-graft insertion followed by an allograft replacement for an infected and ruptured aortic aneurysm. Ann Thorac Cardiovasc Surg. 2009;15:261–4.PubMed Inoue H, Iguro Y, Yamamoto H, Ueno M, Higashi A, Tao K, et al. Palliative stent-graft insertion followed by an allograft replacement for an infected and ruptured aortic aneurysm. Ann Thorac Cardiovasc Surg. 2009;15:261–4.PubMed
42.
go back to reference Ito T, Kurimoto Y, Kawaharada N, Koyanagi T, Hashiguchi H, Yamashita A. Endovascular stent-grafting of anastomotic pseudoaneurysms following thoracic aortic surgery. Gen Thorac Cardiovasc Surg. 2009;57:528–33.CrossRefPubMed Ito T, Kurimoto Y, Kawaharada N, Koyanagi T, Hashiguchi H, Yamashita A. Endovascular stent-grafting of anastomotic pseudoaneurysms following thoracic aortic surgery. Gen Thorac Cardiovasc Surg. 2009;57:528–33.CrossRefPubMed
Metadata
Title
How to treat aortic graft infection? With a special emphasis on xeno-pericardial aortic tube grafts
Authors
Thierry Carrel
Lars Englberger
Jürg Schmidli
Publication date
01-01-2019
Publisher
Springer Japan
Published in
General Thoracic and Cardiovascular Surgery / Issue 1/2019
Print ISSN: 1863-6705
Electronic ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-017-0839-0

Other articles of this Issue 1/2019

General Thoracic and Cardiovascular Surgery 1/2019 Go to the issue